More Videos
SPECIAL REPORT
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Wednesday's Economic News Crunch Could Tilt Markets
- NBA D-League On The Rise
- Obama Reiterates Commitment to Boost US-India Ties
- Australia Wheat Exporters Face Challenges: GrainCorp
- Trading Block
- Stifling Anger at Work Can Kill, Survey Finds
- Japan Export Rebound Eases Fear of New Recession
- Oil Slips Below $76 On Revised US GDP Data
- Gold Hits Record on Dollar, India Buying Talk
- Citi Mortgage Reveals What Treasury Won't
- S&P to Hit 1,200 by Year-End: Chief Investor
- Amended Berkshire Hathaway Filing Indicates No Secret Stock Stakes at End of Q3
- Facebook's Biggest-Ever Holiday Shopping Season
- Facebook's New Dual Class Structure - Slow Steps to an IPO
- 5 Big Bank Stocks Investors Should Consider: Strategists
- Gambling Drunk, Texting to Live And America's On Sale - Your Emails
- Nov. 24: Unusual Volume Leaders
- NBA D-League On The Rise
- FDIC's Bair Cautions on Risks in Bank Break-Up Plan
- Wednesday's Economic News Crunch Could Tilt Markets
- Call Me Crazy: Confessions of a Black Friday Shopper
- US Firms Hit by Payroll Taxes at Exactly the Wrong Time
- Citi Mortgage Reveals Something the US Treasury Won't
- Fed Sanguine About US Recovery, Worried on Jobs
- MGM Pitches Sale to 20 Suitors, Including News Corp
- Holiday Guide to This Season's Smartphones
- Amended Berkshire Filing Reveals No 'Secret' Holdings
PHARMA'S MARKET VIDEO
RSS FEED
Pharma's Market
Text Size 
 |
CNBC.com |
] management at the start of the Q and A portion of the biotech company's analyst meeting? Yep. Mark Schoenebaum from Bear Stearns [BSC
Loading...
()
]. When they get the mike, the analysts all state their names and the firms they work for. And as soon as Schoenebaum said, "Bear Stearns", Genentech CEO Art Levinson yells out, "You mean there's somebody from Bear Stearns still here?" The room erupted in laughter.
Schoenebaum came back with a quick retort, "You guys (the Genentech team) do great work," jokingly hinting he might need to butter them up for a job soon. Genentech's CFO, David Ebersman, used to be a sell-side analyst. By the way, I'll be doing a "First On CNBC" interview with Ebersman on "Closing Bell" at 3 p.m. ET today.
And then toward the end of the Q and A session an analyst gets the mike and once again prefaces his question by introducing himself, "Geoffrey Meacham with JPMorgan...soon to be the parent company, I guess, of Bear Stearns."
Laughter ensues. The meeting ends.
Questions? Comments?
Data is a real-time snapshot *Data is delayed at least 15 minutes